Publication Name	World Journal of Gastroenterology
Manuscript ID	75149
Country	India

Received	2022-01-17 17:06
Peer-Review Started	2022-01-17 17:07
To Make the First Decision
Return for Revision	2022-03-09 01:58
Revised	2022-03-23 14:04
Second Decision	2022-05-18 03:06
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2022-05-22 23:08
Articles in Press	2022-05-22 23:08
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2022-06-26 15:01
Publish the Manuscript Online	2022-07-04 12:30

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Incretin based therapy and pancreatic cancer: Realising the reality
Manuscript Source	Invited Manuscript
All Author List	Varun Suryadevara, Ayan Roy, Jayaprakash Sahoo, Sadishkumar Kamalanathan, Dukhabandhu Naik, Pazhanivel Mohan and Raja Kalayarasan
ORCID	Author(s) ORCID Number Varun Suryadevara http://orcid.org/0000-0002-9230-0734 Ayan Roy http://orcid.org/0000-0003-4419-9376 Jayaprakash Sahoo http://orcid.org/0000-0002-8805-143X Sadishkumar Kamalanathan http://orcid.org/0000-0002-2371-0625 Dukhabandhu Naik http://orcid.org/0000-0003-4568-877X Pazhanivel Mohan http://orcid.org/0000-0003-1473-4382 Raja Kalayarasan http://orcid.org/0000-0003-4056-8672
Funding Agency and Grant Number
Corresponding Author	Jayaprakash Sahoo, MBBS, MD, Additional Professor, Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Room 5444, 4th Floor, Super Speciality Block, Puducherry 605006, India. jppgi@yahoo.com
Key Words	Diabetes mellitus; Dipeptidyl peptidase-4 inhibitor; Glucagon-like peptide-1 receptor agonist; Incretin; Pancreatitis; Pancreatic Cancer
Core Tip	Incretin-based therapies are increasingly being used to treat patients with type 2 diabetes mellitus. The early literature regarding pancreatic safety of incretin-based therapies was discordant. However, the follow-up data of various randomised trials have consistently shown that these medications are safe.
Publish Date	2022-07-04 12:30
Citation	Suryadevara V, Roy A, Sahoo J, Kamalanathan S, Naik D, Mohan P, Kalayarasan R. Incretin based therapy and pancreatic cancer: Realising the reality. World J Gastroenterol 2022; 28(25): 2881-2889
URL	https://www.wjgnet.com/1007-9327/full/v28/i25/2881.htm
DOI	https://dx.doi.org/10.3748/wjg.v28.i25.2881

Full Article (PDF)	WJG-28-2881.pdf
Full Article (Word)	WJG-28-2881.docx
Manuscript File	75149_Auto_Edited-LS.docx
Answering Reviewers	75149-Answering reviewers.pdf
Audio Core Tip	75149-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	75149-Conflict-of-interest statement.pdf
Copyright License Agreement	75149-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	75149-Language certificate.pdf
Peer-review Report	75149-Peer-review(s).pdf
Scientific Misconduct Check	75149-Bing-Fan JR-2.png
Scientific Editor Work List	75149-Scientific editor work list.pdf